Jundishapur Journal of Microbiology

Published by: Kowsar

New Insights into Sepsis Therapy Using Sepia Officinalis

Amel M. Soliman 1 , Sohair R. Fahmy 1 , Amany A. Sayed 1 , * and Asmaa A. Abd El-Latif 1
Authors Information
1 Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
Article information
  • Jundishapur Journal of Microbiology: January 01, 2016, 9 (1); e29331
  • Published Online: January 2, 2016
  • Article Type: Research Article
  • Received: April 19, 2015
  • Revised: September 14, 2015
  • Accepted: September 23, 2015
  • DOI: 10.5812/jjm.29331

To Cite: Soliman A M, Fahmy S R, Sayed A A, Abd El-Latif A A. New Insights into Sepsis Therapy Using Sepia Officinalis, Jundishapur J Microbiol. 2016 ; 9(1):e29331. doi: 10.5812/jjm.29331.

Abstract
Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Ercan M, Ozdemir S. The contribution to studies of the effect of β-glucan on plasma viscosity in a rat sepsis model. Med Sci Discover. 2015; 2(1): 148-53[DOI]
  • 2. Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. 2012; 10(6): 701-6[DOI][PubMed]
  • 3. Dyson A, Singer M. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med. 2009; 37(1 Suppl)-7[DOI][PubMed]
  • 4. Brooks HF, Osabutey CK, Moss RF, Andrews PL, Davies DC. Caecal ligation and puncture in the rat mimics the pathophysiological changes in human sepsis and causes multi-organ dysfunction. Metab Brain Dis. 2007; 22(3-4): 353-73[DOI][PubMed]
  • 5. Dorobat OM, Moisoiu A, Talapan D. [Incidence and resistance patterns of pathogens from lower respiratory tract infections (LRTI)]. Pneumologia. 2007; 56(1): 7-15[PubMed]
  • 6. Fahmy R, Soliman AM. In vitro antioxidant, analgesic and cytotoxic activities of Sepia officinalis ink and Coelatura aegyptiaca extracts. Afr Pharm Pharmacol. 2013; 7(22): 1512-22[DOI]
  • 7. Vairamani S, Subhapradh N, Ramasamy P, Barwin Vin A, Raveendran S, Shanmugam A. Antibacterial activity of methanolic extract of whole body tissue and ethylene diamine tetra acetate extract of cuttlebone of sepiella inermis (orbigny, 1848). Res J Microbiol. 2012; 7(5): 263-72[DOI]
  • 8. Ramasamy P, Vino AB, Saravanan R, Subhapradha N, Shanmugam V, Shanmugam A. Screening of antimicrobial potential of polysaccharide from cuttlebone and methanolic extract from body tissue of Sepia prashadi Winkworth, 1936. Asian Pac J Trop Biomed. 2011; 1(2)-8[DOI]
  • 9. Ely R, Supriya T, Naik CG. Antimicrobial activity of marine organisms collected off the coast of South East India. J Exp Mar Bio Ecol. 2004; 309(1): 121-7[DOI]
  • 10. Okutani K, Morikawa N. Gel-filtration and sugar constituent of the polysaccharide extracted from the internal shell of squid. Bull Jap Soc Fish. 1978; 44(4): 369-72[DOI]
  • 11. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966; 45(4): 493-6[PubMed]
  • 12. Whitehead A, Curnow RN. Statistical evaluation of the fixed-dose procedure. Food ChemToxicol. 1992; 30(4): 313-24[DOI]
  • 13. Liu MW, Su MX, Zhang W, Wang Y, Qin LF, Liu X, et al. Effect of melilotus suaveolens extract on pulmonary microvascular permeability by downregulating vascular endothelial growth factor expression in rats with sepsis. Mol Med Rep. 2015; 11(5): 3308-16[DOI]
  • 14. Nesseler N, Launey Y, Aninat C, Morel F, Mallédant Y, Seguin P. Clinical review: The liver in sepsis. Crit Care. 2012; 16(235): 1-8[DOI]
  • 15. Poli-de-Figueiredo LF, Garrido AG, Nakagawa N, Sannomiya P. Experimental models of sepsis and their clinical relevance. Shock. 2008; 30 Suppl 1: 53-9[DOI][PubMed]
  • 16. Buras JA, Holzmann B, Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov. 2005; 4(10): 854-65[DOI][PubMed]
  • 17. Mayer AM, Rodriguez AD, Berlinck RG, Hamann MT. Marine pharmacology in 2003-4: marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Comp Biochem Physiol C Toxicol Pharmacol. 2007; 145(4): 553-81[DOI][PubMed]
  • 18. Periyasamy N, Murugan S, Bharadhirajan P. Anticoagulant activity of marine gastropods babylonia spirata lin, 1758 and phalium glaucum lin, 1758 collected from cuddalore, southeast cost of INDIA. Int J Pharm Pharm Sci. 2013; 5(4): 117-21
  • 19. Krishnamoorthi J, Sudharsan S, Shanmugam V, Shanmugam A. In vitro antibacterial screening of methanolic extract of whole body tissue and ethylene diamine tetra acetate (EDTA) extract of cuttlebone of Sepia pharaonis (Ehrenberg, 1831) against selected clinical isolates. Afr J Microbiol Res. 2014; 89(40): 3551-7
  • 20. He F, Yang Y, Yang G, Yu L. Studies on antibacterial activity and antibacterial mechanism of a novel polysaccharide from Streptomyces virginia H03. Food Control. 2010; 21(9): 1257-62[DOI]
  • 21. Kong M, Chen XG, Xing K, Park HJ. Antimicrobial properties of chitosan and mode of action: a state of the art review. Int J Food Microbiol. 2010; 144(1): 51-63[DOI][PubMed]
  • 22. Dzoyem JP, Hamamoto H, Ngameni B, Ngadjui BT, Sekimizu K. Antimicrobial action mechanism of flavonoids from Dorstenia species. Drug Discov Ther. 2013; 7(2): 66-72[PubMed]
  • 23. Blanco J, Muriel-Bombin A, Sagredo V, Taboada F, Gandia F, Tamayo L, et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care. 2008; 12(6)[DOI][PubMed]
  • 24. Raoofi R, Salmani Z, Moradi F, Sotoodeh A, Sobhanian S. Procalcitonin as a marker for early diagnosis of sepsis. Am J Infect Dis. 2014; 10(1): 15-20[DOI]
  • 25. Delevaux I, Andre M, Colombier M, Albuisson E, Meylheuc F, Begue RJ, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis. 2003; 62(4): 337-40[PubMed]
  • 26. Yap CYF, Aw TC. The use of procalcitonin in clinical practice. P Singapore Healthcare. 2014; 23(1): 33-7
  • 27. Tavares E, Maldonado R, Minano FJ. Immunoneutralization of endogenous aminoprocalcitonin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Pathol. 2014; 184(11): 3069-83[DOI][PubMed]
  • 28. Bershadsky AD, Futerman AH. Disruption of the Golgi apparatus by brefeldin a blocks cell polarization and inhibits directed cell migration. Proc Natl Acad Sci. 1994; 91(12): 5686-9[DOI]
  • 29. Li H, Luo YF, Blackwell TS, Xie CM. Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections. Antimicrob Agents Chemother. 2011; 55(12): 5900-6[DOI][PubMed]
  • 30. Aird WC. The hematologic system as a marker of organ dysfunction in sepsis. Mayo Clin Proc. 2003; 78(7): 869-81[DOI][PubMed]
  • 31. Goyette RE, Key NS, Ely EW. Hematologic changes in sepsis and their therapeutic implications. Semin Respir Crit Care Med. 2004; 25(6): 645-59[DOI][PubMed]
  • 32. Piagnerelli M, Boudjeltia KZ, Vanhaeverbeek M, Vincent JL. Red blood cell rheology in sepsis. Intensive Care Med. 2003; 29(7): 1052-61[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments